Tag Archive | "Merck KGaA"

Merck KGaA: Partnering activity 2005-2013

Tags: , , , ,

Merck KGaA and Merck Serono announced over 136 partnering / licensing deals since 2005, with 28 deals in 2007 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology Read the full story

Merck KGaA: M&A activity 2005-2013

Tags: , , ,

Merck KGaA has announced 8 M&A deals since 2005, with the lead deal being the acquisition of Serono Read the full story

Merck KGaA and BeiGene collaborate in co-promotion agreement

Tags: , ,

BeiGene and Merck KGaA, a top big pharma company  have entered into a global licensing, co-development, co promotion and commercialization agreement for BeiGene-283. Read the full story

Merck Serono Ventures nets $77.4 in financing facility from Merck KGaA

Tags: , , ,

Merck announced that it will increase its commitment to its strategic corporate venture capital fund Merck Serono Ventures to € 100 million of financing. Read the full story

Merck KGaA / Merck Serono: Company Profile

Tags: , ,

Merck KGaA, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

Pharma partnering: Merck acquires rights for Cetrotide from Aeterna Zentaris

Tags: , ,

Aeterna Zentaris has entered into binding pharma partnering agreements with various partners and licensees with respect to the manufacturing rights and obligations for its Cetrotide product Read the full story

Merck KGaA closes $2.6 billion re financing

Tags: , ,

Merck KGaA, a big pharma company, announced the successful closing of a € 2 billion syndicated loan financing. Read the full story

BMS and Merck Serono enter diabetes drug pharma partnering

Tags: , , ,

Merck Serono announced a pharma partnering agreement for promotion of the type 2 diabetes drug Glucophage (metformin hydrochloride) under different formulations in China. Read the full story

Big pharma companies and academics collaborate for drug development

Tags: , , , , , , , ,

Seven European big pharma drugmakers are to pool their research efforts with academic scientists and smaller companies in a new 196 million euros ($265 million) project designed to find tomorrow's medicines. Read the full story

Merck KGaA co-operates with Symphogen in worldwide pharma licensing pact

Tags: , , ,

Merck KGaA, a top big pharma company announced the signing of a worldwide pharma licensing agreement with Symphogen, for Sym004, an investigational antibody mixture targeting the epidermal growth factor receptor (EGFR).

Read the full story